Style | Citing Format |
---|---|
MLA | Sa Seyedalinaghi Seyedahmad AHMAD, E Mehraeen ESMAEIL. "Can an International Student Group at Tums in Iran Be a Role Model in the Development of Applied Scientific Evidence in the Era of Covid-19 Through Mentorship?." Infectious Disorders - Drug Targets, vol. 24, no. 7, 2024, pp. 18-20. |
APA | Sa Seyedalinaghi Seyedahmad AHMAD, E Mehraeen ESMAEIL (2024). Can an International Student Group at Tums in Iran Be a Role Model in the Development of Applied Scientific Evidence in the Era of Covid-19 Through Mentorship?. Infectious Disorders - Drug Targets, 24(7), 18-20. |
Chicago | Sa Seyedalinaghi Seyedahmad AHMAD, E Mehraeen ESMAEIL. "Can an International Student Group at Tums in Iran Be a Role Model in the Development of Applied Scientific Evidence in the Era of Covid-19 Through Mentorship?." Infectious Disorders - Drug Targets 24, no. 7 (2024): 18-20. |
Harvard | Sa Seyedalinaghi Seyedahmad AHMAD, E Mehraeen ESMAEIL (2024) 'Can an International Student Group at Tums in Iran Be a Role Model in the Development of Applied Scientific Evidence in the Era of Covid-19 Through Mentorship?', Infectious Disorders - Drug Targets, 24(7), pp. 18-20. |
Vancouver | Sa Seyedalinaghi Seyedahmad AHMAD, E Mehraeen ESMAEIL. Can an International Student Group at Tums in Iran Be a Role Model in the Development of Applied Scientific Evidence in the Era of Covid-19 Through Mentorship?. Infectious Disorders - Drug Targets. 2024;24(7):18-20. |
BibTex | @article{ author = {Sa Seyedalinaghi Seyedahmad AHMAD and E Mehraeen ESMAEIL}, title = {Can an International Student Group at Tums in Iran Be a Role Model in the Development of Applied Scientific Evidence in the Era of Covid-19 Through Mentorship?}, journal = {Infectious Disorders - Drug Targets}, volume = {24}, number = {7}, pages = {18-20}, year = {2024} } |
RIS | TY - JOUR AU - Sa Seyedalinaghi Seyedahmad AHMAD AU - E Mehraeen ESMAEIL TI - Can an International Student Group at Tums in Iran Be a Role Model in the Development of Applied Scientific Evidence in the Era of Covid-19 Through Mentorship? JO - Infectious Disorders - Drug Targets VL - 24 IS - 7 SP - 18 EP - 20 PY - 2024 ER - |